Skip to main content

Table 3 Results of patient questionnaires (n = 114)

From: Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study

  Very acceptable (%) Acceptable (%) Uncertain (%) Unacceptable (%) Very unacceptable (%)
Q1: How do you feel about the information you have received regarding this pilot project? 71 28 1 0 0
Q2: How do you feel about the opportunity given to you to ask any questions about the test and/or dosing method? 77 22 1 0 0
Q3: How did you feel about giving a mouth swab sample? 72 28 0 0 0
Q4: How did you feel about waiting to receive your warfarin doses? 51 43 5 1 0
Q5: How did you feel about coming back to clinic in a short space of time? 46 46 4 4 0
Q6: How would you rate your overall experience? 60 35 4 1 0